Inside the Report:

In partnership with Ipsos, ixlayer surveyed over 400 patients with chronic conditions to explore their motivations, barriers, and expectations around digital health. The findings offer a clear blueprint for biopharma companies looking to deliver more seamless, supportive, and scalable direct-to-patient (DTP) solutions.

  • Why 81% of patients believe pharma should help them access care and medicine
  • The digital health services patients want most—from at-home testing to telehealth and pharmacy delivery
  • The top factors driving satisfaction (and dissatisfaction) with digital tools
  • How pharma can improve perception, access, and adherence through integrated digital offerings

Inside the Report

In partnership with Ipsos, ixlayer surveyed patients with chronic conditions to explore their motivations, barriers, and expectations around digital health. The findings offer a clear blueprint for biopharma companies looking to deliver more seamless, supportive, and scalable direct-to-patient (DTP) solutions. This report sheds light on:

  • Why 81% of respondents believe biopharma should help them access the care and medicines they need
  • The digital health services respondents want most—from easier access to lab testing to telehealth and pharmacy delivery
  • The top factors driving satisfaction (and dissatisfaction) with digital tools
  • How biopharma can improve perception, access, and adherence through integrated digital offerings

ixInsights 2025 Report